- Tytuł:
- Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
- Autorzy:
- Źródło:
- Targeted Oncology. 17(6):643-653
Czasopismo naukowe